Literature DB >> 19590002

Discovery of swine as a host for the Reston ebolavirus.

Roger W Barrette1, Samia A Metwally, Jessica M Rowland, Lizhe Xu, Sherif R Zaki, Stuart T Nichol, Pierre E Rollin, Jonathan S Towner, Wun-Ju Shieh, Brigid Batten, Tara K Sealy, Consuelo Carrillo, Karen E Moran, Alexa J Bracht, Gregory A Mayr, Magdalena Sirios-Cruz, Davinio P Catbagan, Elizabeth A Lautner, Thomas G Ksiazek, William R White, Michael T McIntosh.   

Abstract

Since the discovery of the Marburg and Ebola species of filovirus, seemingly random, sporadic fatal outbreaks of disease in humans and nonhuman primates have given impetus to identification of host tropisms and potential reservoirs. Domestic swine in the Philippines, experiencing unusually severe outbreaks of porcine reproductive and respiratory disease syndrome, have now been discovered to host Reston ebolavirus (REBOV). Although REBOV is the only member of Filoviridae that has not been associated with disease in humans, its emergence in the human food chain is of concern. REBOV isolates were found to be more divergent from each other than from the original virus isolated in 1989, indicating polyphyletic origins and that REBOV has been circulating since, and possibly before, the initial discovery of REBOV in monkeys.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590002     DOI: 10.1126/science.1172705

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  155 in total

1.  Ebola virus transmission in guinea pigs.

Authors:  Gary Wong; Xiangguo Qiu; Jason S Richardson; Todd Cutts; Brad Collignon; Jason Gren; Jenna Aviles; Carissa Embury-Hyatt; Gary P Kobinger
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs.

Authors:  Jin Huk Choi; Stephen C Schafer; Lihong Zhang; Gary P Kobinger; Terry Juelich; Alexander N Freiberg; Maria A Croyle
Journal:  Mol Pharm       Date:  2011-12-15       Impact factor: 4.939

Review 3.  Filovirus vaccines.

Authors:  Steven B Bradfute; John M Dye; Sina Bavari
Journal:  Hum Vaccin       Date:  2011-06-01

4.  Assessment of rodents as animal models for Reston ebolavirus.

Authors:  Emmie de Wit; Vincent J Munster; Samia A Metwally; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

Review 5.  Microbe hunting.

Authors:  W Ian Lipkin
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

6.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

7.  Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.

Authors:  Jens H Kuhn; Stephan Becker; Hideki Ebihara; Thomas W Geisbert; Karl M Johnson; Yoshihiro Kawaoka; W Ian Lipkin; Ana I Negredo; Sergey V Netesov; Stuart T Nichol; Gustavo Palacios; Clarence J Peters; Antonio Tenorio; Viktor E Volchkov; Peter B Jahrling
Journal:  Arch Virol       Date:  2010-10-30       Impact factor: 2.574

8.  Structural basis for Marburg virus neutralization by a cross-reactive human antibody.

Authors:  Takao Hashiguchi; Marnie L Fusco; Zachary A Bornholdt; Jeffrey E Lee; Andrew I Flyak; Rei Matsuoka; Daisuke Kohda; Yusuke Yanagi; Michal Hammel; James E Crowe; Erica Ollmann Saphire
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

9.  Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression.

Authors:  Christopher R Kimberlin; Zachary A Bornholdt; Sheng Li; Virgil L Woods; Ian J MacRae; Erica Ollmann Saphire
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

10.  Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs.

Authors:  Xiangguo Qiu; Gary Wong; Lisa Fernando; Jane Ennis; Jeffrey D Turner; Judie B Alimonti; Xiaojian Yao; Gary P Kobinger
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.